The present invention relates to an antimicrobial composition comprising copper and zinc incorporated into or coated on a substrate material, wherein the substrate comprises a dermatological composition for external use on a subject. The invention also relates to methods of making the described antimicrobial materials.

A prophylactic cream, ointment or deodorant for the prevention of the formation of yeast infections.

A composition for lubricant formulations is disclosed. The composition may include hypochlorite, dimethicone, and an emulsifier for improvement of lubricity. Methods of making and using the lubricant formulations are also disclosed.

A treatment solution contains a topical anesthetic, an anesthetic solvent, and a carrier fluid, wherein the treatment solution is essentially free of alcohol. A treatment solution contains an antifungal agent, a topical anesthetic, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution is essentially free of alcohol. A treatment solution contains a topical anesthetic, an anesthetic solvent, and a carrier fluid, wherein the treatment solution has an alcohol content of 15 wt% or below of the total solution. A treatment solution contains an antifungal agent, a topical anesthetic, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution has an alcohol content of 15 wt% or below of the total solution.

The invention relates to a novel composition and method of manufacturing personal lubricant, commonly known as lube, to combine the most desirable features of disparate existing lube compositions to create a long lasting, oil-based, water soluble, non-toxic, anti-microbial, anti-yeast, non-staining, personal lubricant that can be organically sourced and will not damage commonly used prophylactics.

The invention refers to an antimicrobial, exfoliating and seboregulating hydrosoluble composition comprising a combination of diallyl disulphide modified oxide (DDMO) and alpha hydroxyethanoic acid (glycolic acid), which acts removing bacteria affecting the skin including those caused by acne, said composition also provides deep cleansing, exfoliating action, reduces epidermal cohesion facilitating cellular change, preventing the occurrence of several forms of acne in the skin and additionally producing seboregulating effects by avoiding blockage of sebaceous glands.

The present invention relates to a stable protease formulation. Furthermore, it relates to a stable protease formulation for use in medicine and cosmetics, as well as a method of preventing and reducing biofilm formulation.

The present disclosure relates to antimicrobial skin disinfectant compositions such as hand disinfectant soaps, comprising one or more quaternary ammonium compounds, one or more surfactants and an aromatic alcohol, achieving anti-bacterial and fungicidal or yeasticidal efficacy in short contact times.

In some embodiments, a composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals. In some embodiments, a composition is disclosed that includes silk fibroin-based protein fragments and is suitable for use in consumer applications. In some embodiments, a preserved composition is disclosed that includes silk fibroin-based protein fragments. In some embodiments, a method of preserving a solution using silk fibroin-based protein fragments is disclosed.

Novel antimicrobial compositions and kits thereof containing these antimicrobial compositions, methods of manufacture and methods of use thereof are disclosed. The novel aqueous transdermal or topical delivery systems are useful, inter alia, for treatment of various microbial infections, including for use on tissue infections, particularly skin antisepsis and/or nasal mucosal tissue antisepsis to a mammalian host in need thereof.